RMDI
NVS icon

R.M. Davis Inc’s Novartis NVS Stock Holding History

R.M. Davis Inc’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,747
Closed -$267K – 284
2026
Q1 		$267K Buy
+1,747
New +$268K ﹤0.01% 247
2025
Q3 		– Sell
-1,956
Closed -$237K – 286
2025
Q2 		$237K Sell
1,956
-173
-8% -$19.5K ﹤0.01% 251
2025
Q1 		$237K Sell
2,129
-45
-2% -$4.79K ﹤0.01% 255
2024
Q4 		$212K Buy
2,174
+65
+3% +$6.93K ﹤0.01% 267
2024
Q3 		$243K Sell
2,109
-90
-4% -$10.2K ﹤0.01% 255
2024
Q2 		$234K Buy
2,199
+100
+5% +$10K ﹤0.01% 256
2024
Q1 		$203K Sell
2,099
-250
-11% -$25.6K ﹤0.01% 257
2023
Q4 		$237K Buy
2,349
+250
+12% +$24.1K 0.01% 245
2023
Q3 		$214K Buy
+2,099
New +$213K 0.01% 257
2023
Q2 		– Sell
-3,559
Closed -$327K – 280
2023
Q1 		$327K Hold
3,559
– – 0.01% 220
2022
Q4 		$323K Sell
3,559
-13
-0.4% -$1.09K 0.01% 220
2022
Q3 		$272K Buy
3,572
+58
+2% +$4.81K 0.01% 226
2022
Q2 		$297K Hold
3,514
– – 0.01% 217
2022
Q1 		$308K Sell
3,514
-500
-12% -$43.3K 0.01% 229
2021
Q4 		$351K Sell
4,014
-701
-15% -$58.2K 0.01% 214
2021
Q3 		$386K Buy
4,715
+101
+2% +$9.09K 0.01% 195
2021
Q2 		$421K Buy
4,614
+325
+8% +$28.9K 0.01% 188
2021
Q1 		$367K Sell
4,289
-695
-14% -$62.4K 0.01% 197
2020
Q4 		$471K Buy
4,984
+2,241
+82% +$196K 0.01% 175
2020
Q3 		$239K Buy
2,743
+275
+11% +$23.8K 0.01% 218
2020
Q2 		$216K Buy
+2,468
New +$213K 0.01% 222
2020
Q1 		– Sell
-2,374
Closed -$225K – 245
2019
Q4 		$225K Sell
2,374
-54
-2% -$4.84K 0.01% 231
2019
Q3 		$211K Buy
2,428
+133
+6% +$11.9K 0.01% 228
2019
Q2 		$210K Sell
2,295
-266
-10% -$22.5K 0.01% 228
2019
Q1 		$221K Sell
2,561
-285
-10% -$22.9K 0.01% 212
2018
Q4 		$219K Buy
2,846
+250
+10% +$19.5K 0.01% 204
2018
Q3 		$200K Buy
+2,596
New +$192K 0.01% 223
2018
Q2 		– Sell
-2,930
Closed -$212K – 234
2018
Q1 		$212K Buy
2,930
+112
+4% +$8.53K 0.01% 222
2017
Q4 		$212K Hold
2,818
– – 0.01% 228
2017
Q3 		$217K Sell
2,818
-70
-2% -$5.29K 0.01% 215
2017
Q2 		$216K Buy
+2,888
New +$205K 0.01% 209
2017
Q1 		– Sell
-3,772
Closed -$246K – 221
2016
Q4 		$246K Buy
3,772
+558
+17% +$36.2K 0.01% 195
2016
Q3 		$227K Sell
3,214
-564
-15% -$41.1K 0.01% 190
2016
Q2 		$279K Sell
3,778
-312
-8% -$21.6K 0.01% 178
2016
Q1 		$265K Sell
4,090
-596
-13% -$40.5K 0.01% 170
2015
Q4 		$361K Sell
4,686
-865
-16% -$68.7K 0.02% 162
2015
Q3 		$457K Buy
5,551
+730
+15% +$65K 0.02% 152
2015
Q2 		$425K Sell
4,821
-118
-2% -$10.8K 0.02% 150
2015
Q1 		$436K Buy
4,939
+1,016
+26% +$90.1K 0.02% 149
2014
Q4 		$326K Buy
3,923
+608
+18% +$50.4K 0.02% 156
2014
Q3 		$280K Sell
3,315
-1,740
-34% -$141K 0.02% 161
2014
Q2 		$410K Buy
5,055
+936
+23% +$73.6K 0.02% 146
2014
Q1 		$314K Sell
4,119
-183
-4% -$13.3K 0.02% 155
2013
Q4 		$310K Sell
4,302
-89
-2% -$6.19K 0.02% 160
2013
Q3 		$302K Buy
+4,391
New +$291K 0.02% 152

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

R.M. Davis Inc's NVS Position: Q2 2026 in Review

R.M. Davis Inc sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,747 shares — an estimated $267K sold.

R.M. Davis Inc first reported a position in NVS in Q3 2013 and held it in 45 quarters. The position peaked at $471K in Q4 2020. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • R.M. Davis Inc reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • R.M. Davis Inc sold 1,747 Novartis shares in Q2 2026, an estimated $267K.
  • R.M. Davis Inc first reported a position in Novartis in Q3 2013 and held it in 45 quarters.
  • R.M. Davis Inc's Novartis position peaked at $471K in Q4 2020.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.